Laddar...
Triple versus guideline antiplatelet therapy to prevent recurrence after acute ischaemic stroke or transient ischaemic attack: the TARDIS RCT.
BACKGROUND: Two antiplatelet agents are better than one for preventing recurrent stroke after acute ischaemic stroke or transient ischaemic attack (TIA). Therefore, intensive treatment with three agents might be better still, providing it does not cause undue bleeding. OBJECTIVE: To compare the safe...
Sparad:
| I publikationen: | Health Technol Assess |
|---|---|
| Huvudupphovsmän: | , , , , , , , , , , , , , , , , , , , , , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
NIHR Journals Library
2018
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6139477/ https://ncbi.nlm.nih.gov/pubmed/30179153 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3310/hta22480 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|